Society Letters

Letter to President Trump on the American Health Supply Chain

March 27, 2020

To: President Donald J. Trump

"Today, patients in the United States and around the world depend on the use of global supply chains that facilitate ongoing access to needed medicines. These supply chains have been built over decades and include appropriate safeguards to ensure safety and efficacy of products. Keeping that supply chain strong is even more critical as we fight a global pandemic. That’s why the biopharmaceutical industry has been working together with the U.S. Food and Drug Administration to take significant steps to ensure continuity in our medicine supply. Proposals to drive all manufacturing to the United States not only overestimate the potential feasibility and underestimate the time and effort it would take to make such changes, but also misunderstand that a diverse pharmaceutical supply chain is precisely what enables the industry to respond quickly and make adjustments in its supply chain sourcing during natural emergencies and global public health crises."

arrowRead the Full Letter

Last Updated:
Take Action

Make Your Voice Heard

Take Action
Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!